| Issue Type | XXXX |
|---|---|
| Country | Israel |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2027-05-09 |
| Par Value | 100000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 1100.00 |
| Coupon | 3.75 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 1100.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Teva Pharmaceutical Finance Netherlands II B.V. corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million EUR and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Teva Pharmaceutical Finance Netherlands II B.V., established in the Netherlands, serves as a finance subsidiary of Teva Pharmaceutical Industries Ltd., headquartered in Israel. The company primarily focuses on raising funds through the issuance of bonds to support the broader financing needs of its parent organization and facilitate operational growth.